Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,3499,84,3.45 [2.46-4.84],5.951772669236575e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",4107,122,2.52 [2.14-2.96],3.3809275512939656e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,4138,120,12.68 [9.20-17.49],3.587382345143674e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,4162,122,2.93 [2.22-3.85],1.8524378128743835e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,3506,87,3.93 [2.91-5.33],7.8084787770226455e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,4145,120,7.73 [5.22-11.44],1.9828546062090573e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,4228,121,10.74 [6.32-18.25],1.6111056917942553e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,4206,121,3.84 [2.59-5.70],2.487660167061316e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,3602,89,7.07 [5.11-9.77],2.776834196379162e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,4161,121,3.10 [2.34-4.12],5.812903745478369e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,4138,120,4.70 [3.58-6.17],6.957040399941588e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,3602,89,2.25 [1.67-3.03],9.745192359190417e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,4198,120,7.15 [4.51-11.35],6.509931269785811e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,4215,123,5.01 [3.59-6.98],2.0431587302578387e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,4215,123,22.79 [13.30-39.05],5.674091484099073e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,4172,120,3.43 [2.47-4.76],1.872624749384916e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,4027,115,1.73 [1.50-1.99],1.7091062305629546e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,4198,120,4.77 [3.75-6.07],3.6403457267375394e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,4228,121,2.84 [2.10-3.85],1.4622587800045306e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,4232,123,9.31 [4.90-17.69],9.941646232326812e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,4211,123,33.66 [20.12-56.29],6.127565429750837e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,4182,122,3.66 [2.55-5.25],1.973043054688563e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,4215,123,3.54 [2.52-4.97],2.5680448431568083e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,4192,120,4.19 [3.01-5.81],1.3524223463760249e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,4042,116,3.08 [2.34-4.04],5.950949298946917e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,4197,122,8.43 [5.40-13.16],7.357652651818137e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,3632,90,3.04 [2.12-4.34],1.110997354224723e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,3631,89,4.40 [3.15-6.16],4.925174158272326e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,4161,121,3.58 [2.81-4.56],3.4708091484715063e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,4197,122,7.31 [5.48-9.76],1.4966691144088848e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,4145,120,6.52 [4.73-8.98],1.725915292781874e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,3632,90,11.22 [6.88-18.30],3.7002944612595313e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,3602,89,6.06 [4.56-8.06],2.4105511802761584e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,4197,122,6.59 [4.16-10.47],1.1812629598689748e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,3631,89,7.28 [5.14-10.31],4.5279099299509364e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",3520,84,4.46 [2.58-7.71],8.97444658136254e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",4198,120,13.61 [9.43-19.64],3.286102955964928e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,4058,119,4.00 [3.12-5.14],1.7044858430378578e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,3556,85,3.89 [2.58-5.87],1.0324180114385428e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,3556,85,7.79 [4.91-12.36],3.0861274859679122e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,4107,122,8.87 [5.00-15.74],8.587866531744799e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,4220,121,22.46 [14.69-34.33],8.678396313506076e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,4198,120,10.44 [7.94-13.74],4.3212883763357527e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,4174,120,5.71 [4.25-7.66],6.383674327595325e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,4206,121,6.71 [4.00-11.25],5.922380481119143e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,4161,121,4.92 [3.98-6.09],5.7704282544426994e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,4215,123,4.73 [3.52-6.35],4.328741066707251e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,4232,123,8.81 [5.26-14.76],1.350616715109864e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,4215,123,2.39 [1.91-3.00],2.0353739547597023e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,4161,121,3.36 [2.58-4.38],4.0156629340045016e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,4054,117,4.58 [3.29-6.37],2.203038860381204e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,4137,120,1.95 [1.66-2.30],1.1995642586972709e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,3602,87,2.20 [1.79-2.69],3.3366774363589993e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,4166,120,11.31 [5.59-22.89],1.500526834251319e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,4149,122,2.01 [1.63-2.48],4.7268371002553777e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,4181,121,1.65 [1.38-1.97],2.6797210273122765e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,4181,121,4.23 [3.29-5.45],4.8607534324966797e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,4228,121,3.69 [2.53-5.38],1.3855480418165451e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,4182,122,3.48 [2.68-4.51],9.167706348335206e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,4232,123,3.79 [2.94-4.88],7.136294349275773e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,4232,123,2.22 [1.68-2.94],2.172229539052504e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,4198,120,2.73 [1.94-3.83],6.794382257345705e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,4228,121,3.26 [2.40-4.41],2.5244546037418532e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,4218,123,6.32 [4.88-8.20],4.28640779072516e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,4215,123,5.54 [4.18-7.35],1.5718084779494358e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,4195,121,5.74 [4.18-7.88],3.3183507083744105e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,4195,121,3.42 [2.19-5.33],5.6639310800994544e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,4120,121,4.55 [3.44-6.01],1.4622939506845083e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,4228,121,4.58 [3.66-5.74],7.170127123233902e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,4195,121,1.95 [1.62-2.35],2.032989246202365e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,4174,120,4.20 [3.08-5.73],1.1130969279139095e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,4091,118,4.97 [3.51-7.03],1.3145106869224193e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,4185,121,6.44 [5.18-8.01],3.861347388151008e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,4145,120,3.39 [2.63-4.39],8.626598289926527e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,4176,120,6.75 [4.87-9.35],1.5598963727347588e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,4058,119,3.07 [2.26-4.17],7.74142233039923e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,3556,85,14.29 [8.74-23.39],3.3302855553291514e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,4212,121,9.99 [7.00-14.25],5.7115727510180845e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,4202,123,5.64 [4.35-7.30],3.5204243856242405e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,4215,123,3.04 [2.34-3.97],1.520390480546075e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,4195,121,7.31 [5.39-9.94],3.771341857139342e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,4161,121,8.82 [6.73-11.56],4.553623650516952e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4161,121,7.07 [5.20-9.60],6.754520469591438e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,4169,120,3.88 [2.95-5.10],2.279341969397594e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,4182,120,2.03 [1.59-2.59],1.243721855045122e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,4166,122,10.60 [7.08-15.87],1.9103421610064647e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,4192,120,8.22 [5.38-12.56],1.850629629352902e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,4211,123,3.97 [3.17-4.98],5.1335762903473386e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,4033,114,6.58 [4.89-8.86],2.3289435594985336e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,4023,119,11.93 [8.68-16.41],1.61794122737483e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,3496,87,3.58 [2.73-4.70],3.403431385933858e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,4174,120,2.55 [1.87-3.46],2.456151038679738e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,3556,85,3.21 [2.29-4.49],1.1197349854203991e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,4212,121,9.69 [6.95-13.51],6.446414490206752e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,4228,121,4.96 [4.07-6.04],3.0787366567415773e-57
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,4174,120,5.79 [4.19-8.00],1.973017040511262e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,4048,117,8.26 [5.93-11.50],8.409348114828247e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,4195,121,36.15 [21.06-62.03],9.29310819013948e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,4195,121,12.54 [7.41-21.22],4.639028377115525e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,4035,117,2.97 [2.47-3.58],1.495780344408154e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,4181,121,1.84 [1.52-2.22],3.1482544446227006e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,4212,121,6.22 [4.70-8.24],2.1744355921273364e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,4181,121,2.77 [1.96-3.92],8.051944645794852e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,4161,121,16.71 [10.52-26.53],7.689835340031726e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,4209,121,4.64 [3.50-6.16],1.8741117105641958e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,3602,89,3.06 [2.19-4.27],5.4559264800505426e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,4107,122,2.40 [1.86-3.09],1.5085054286612054e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,3556,85,7.39 [4.53-12.08],1.3863676098827612e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,3631,89,10.42 [6.03-18.02],4.824508650329182e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,4195,121,1.94 [1.65-2.28],5.3716747403632325e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,4181,121,4.95 [3.80-6.45],1.2283303320536432e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",3602,87,5.90 [4.52-7.71],5.7571726490406056e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,3607,90,2.37 [1.74-3.22],3.96254134311894e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,3629,87,1.58 [1.38-1.81],3.811215818392748e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,4195,121,5.12 [3.98-6.59],4.5949935089253584e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,4085,119,1.77 [1.51-2.07],1.459731555689925e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,4192,120,11.13 [7.75-15.99],8.00902539284568e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,3629,87,2.85 [2.05-3.95],3.717298866542724e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,4211,121,5.15 [4.18-6.33],5.560037649791046e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,3629,87,3.22 [2.50-4.14],1.1523493086458722e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,4174,121,1.79 [1.47-2.18],6.701168048466633e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,4145,120,4.07 [2.65-6.26],1.6371088980011535e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,4195,121,11.76 [8.50-16.26],3.491556636009352e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,4107,122,7.04 [5.31-9.33],4.358338006583279e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,4174,120,2.37 [1.93-2.89],4.6032845032038167e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,4172,121,6.74 [4.70-9.65],2.6134212629780302e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,4058,119,2.58 [2.02-3.30],5.1465988718712734e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,4228,121,4.49 [3.44-5.87],3.4711024501345555e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,4215,123,31.18 [20.51-47.42],3.221924040875921e-58
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,4232,123,4.70 [2.71-8.14],3.5760936733284566e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,3629,87,5.94 [3.72-9.50],9.107428374696892e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,4195,123,28.99 [17.81-47.19],8.681557576714201e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,4181,121,2.54 [1.98-3.26],2.7546063359528906e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,4232,123,8.19 [6.32-10.62],7.793881812711504e-57
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,4176,120,15.99 [11.26-22.70],3.471718147263653e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,3615,89,10.81 [6.13-19.08],2.1281915163018188e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,3556,85,4.61 [2.92-7.29],6.049215857080638e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,4192,120,2.40 [1.90-3.02],9.724095430012309e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,4176,120,6.85 [3.92-11.98],1.5187035813554756e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,4198,120,17.81 [9.77-32.48],5.660543431906468e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,4145,120,3.23 [2.45-4.26],8.526961760012564e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,4145,120,2.62 [1.95-3.50],1.1499445587206435e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,4198,120,13.38 [8.97-19.96],4.946524323094744e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,3629,87,6.51 [3.80-11.13],8.216478106259632e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,4181,121,10.27 [7.45-14.15],6.6171825920679835e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,4064,121,3.72 [2.82-4.89],8.105285565988523e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,4131,120,3.07 [2.21-4.27],2.14418583511478e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,3629,87,5.82 [3.84-8.83],1.2202747713385587e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,4182,123,2.45 [1.89-3.17],1.621271697124421e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,4181,121,5.13 [3.14-8.36],6.147030037665919e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,4228,121,3.62 [2.38-5.52],2.102434859013531e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,4186,122,6.20 [4.16-9.23],2.61760350697311e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,4145,120,5.93 [4.40-7.99],1.85947573345565e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,4174,120,3.25 [2.52-4.18],5.231454964962095e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,4228,123,14.05 [8.74-22.59],1.0279336400103807e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,4198,120,1.98 [1.66-2.35],1.0127143500297315e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,3629,87,6.79 [3.94-11.69],5.290391739107116e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",4185,121,6.38 [4.26-9.55],2.218537598523036e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,4107,122,11.87 [7.16-19.68],8.86689567747361e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4161,121,2.34 [1.72-3.18],5.4327301534076767e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,4212,121,6.48 [3.81-10.99],4.570673705975348e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,4088,118,2.29 [1.91-2.75],5.035247650861299e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,4232,123,8.13 [5.10-12.98],1.5378200984948261e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,4140,120,3.39 [2.70-4.26],5.188685131158293e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,4232,123,2.47 [1.91-3.18],3.418753728707079e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,4185,121,14.53 [10.54-20.02],3.4714433929140473e-60
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,4232,123,35.41 [18.47-67.91],6.68232665006028e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,4202,123,1.97 [1.63-2.38],3.037075652809654e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,4145,120,4.53 [3.33-6.16],7.5958859401080125e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,4152,119,3.74 [3.16-4.44],1.3257269247250882e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,4195,121,5.92 [3.95-8.88],8.500515585400593e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,4202,123,4.98 [3.36-7.37],9.858167123603617e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,3601,89,3.07 [2.30-4.11],4.2202389683295064e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,4161,121,8.59 [5.61-13.17],5.1624909484774633e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,4207,123,6.64 [4.35-10.14],1.7944063660291015e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,4215,123,6.19 [5.01-7.64],2.040532234947837e-64
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,4107,122,2.43 [1.76-3.36],8.495949861758987e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,3520,84,8.50 [5.03-14.35],1.241865973936984e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,3602,89,7.95 [5.60-11.27],2.8460398407257584e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,4193,122,9.40 [6.56-13.46],2.876791149011285e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,3616,90,3.52 [2.70-4.60],1.997031568061742e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,4191,121,11.67 [8.73-15.61],1.563820090946891e-61
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,4138,120,10.69 [8.21-13.92],2.467908976043724e-69
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,3532,86,1.64 [1.38-1.96],2.354859482976312e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,4058,119,2.46 [1.77-3.42],7.427514798816007e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,3602,89,3.44 [2.36-5.03],1.5063957900384283e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,3615,89,6.58 [4.17-10.37],5.014619832204218e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,4080,118,2.01 [1.60-2.53],1.6746184908344187e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,3334,81,2.71 [2.16-3.41],1.5744049039563653e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,4190,120,8.33 [5.33-13.01],1.2345209584014062e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,4027,119,7.89 [6.25-9.96],1.991992425184941e-67
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,3556,85,11.00 [5.89-20.54],5.120017695181044e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,4232,123,13.31 [9.95-17.79],2.5286662524557488e-68
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,4137,120,9.07 [6.51-12.63],6.578777304896355e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,4210,123,4.90 [3.53-6.81],3.0328966131342895e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,4232,123,8.62 [6.16-12.07],4.009378999137929e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,4188,123,9.23 [5.98-14.26],1.2406104555634652e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",4176,120,1.98 [1.72-2.28],6.254193925895428e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",4181,121,1.84 [1.58-2.15],9.180971868644614e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",3615,89,3.21 [2.59-3.97],7.546410871458147e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",4232,123,3.02 [2.48-3.67],1.037046709800883e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,4101,121,2.00 [1.65-2.42],1.722732093885587e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,4161,121,5.31 [3.72-7.57],2.913808154142602e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,4181,121,15.04 [10.75-21.05],2.0322348510895208e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,3602,89,1.99 [1.58-2.51],6.175441319074618e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,4222,123,2.37 [1.93-2.91],1.4273347433757436e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,3629,87,6.85 [4.50-10.41],2.3230268310456983e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,4195,121,2.13 [1.79-2.52],4.819842483414265e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,4209,120,1.91 [1.51-2.41],7.959198012429018e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,4204,123,1.98 [1.71-2.29],4.0459181153878916e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,4080,118,3.89 [2.93-5.15],3.822165245794308e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,4185,121,5.87 [3.83-9.00],4.544296808147642e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,3632,90,2.48 [1.89-3.25],5.0448552331712365e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,4145,120,6.14 [4.35-8.68],7.745734094584338e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,4156,121,2.70 [2.00-3.63],5.943854912080951e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,4167,121,12.02 [8.42-17.17],1.3840264964646957e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,4212,121,6.54 [4.16-10.29],4.392192867950844e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,3520,84,16.61 [8.27-33.35],2.7521340554337122e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,4174,119,8.88 [6.69-11.79],1.3173128105018838e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,4209,123,9.13 [5.16-16.15],2.928637417332659e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,4058,119,1.52 [1.34-1.72],4.3918273278398524e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",4161,121,3.13 [2.07-4.73],6.414044407456251e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,4232,123,3.38 [2.87-3.99],4.6915037014671355e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,4207,123,21.26 [14.89-30.36],1.7393787314630078e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,4161,121,9.21 [4.47-18.96],1.6775969299360571e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,4136,120,8.37 [5.66-12.39],2.3831519971114988e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,4145,120,8.92 [5.61-14.19],2.1845920135317627e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,3602,87,6.91 [4.49-10.63],1.4589791721380925e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,4215,123,10.92 [6.77-17.61],1.0883722645851471e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,4079,116,6.45 [3.87-10.76],8.779480214361542e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,4107,122,4.10 [3.32-5.07],2.1911715757375326e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,4174,121,9.41 [5.63-15.75],1.3468880907467557e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,4175,121,6.40 [4.99-8.20],1.0508228001115755e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,4211,123,3.14 [2.76-3.56],1.3004760315062634e-69
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,4195,121,7.89 [5.86-10.62],2.9063472901272025e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,3615,89,12.76 [6.17-26.43],6.884073394824094e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,3598,87,1.66 [1.42-1.94],1.5063851599740372e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",4174,120,5.64 [4.37-7.28],3.509347196689387e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,4126,119,2.24 [1.72-2.93],2.4328698827056164e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,3520,84,2.45 [1.89-3.17],9.826804002212018e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,3506,87,3.77 [2.71-5.24],3.422151100634705e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,3607,90,2.70 [2.12-3.44],8.83969193333515e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,4215,123,4.65 [3.54-6.11],1.5488303926651687e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,4161,122,8.29 [6.22-11.05],2.916108950170386e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,4232,123,31.24 [18.71-52.17],1.619370683676791e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,4232,123,5.26 [3.19-8.66],7.610148136965269e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,3511,86,3.52 [2.26-5.47],2.2847844945727546e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,4198,120,22.63 [13.86-36.92],9.191619122886319e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,4161,121,11.37 [7.56-17.09],1.5644396509680638e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,4228,123,1.65 [1.46-1.88],5.4995788074358916e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,4225,123,3.24 [2.64-3.98],4.897398320323064e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,4143,118,4.57 [3.84-5.45],2.655393160340953e-64
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,4174,121,6.53 [5.08-8.39],1.3986600761027084e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,4232,123,3.83 [2.98-4.91],4.0922162535392703e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,4181,121,3.47 [2.55-4.71],2.1127565882685977e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,3621,89,3.39 [2.25-5.10],5.177203853856576e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,4181,121,3.34 [2.59-4.31],1.7565377881405746e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,4198,120,10.09 [7.12-14.29],9.96564824044688e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,4161,121,2.01 [1.70-2.36],9.312962127472436e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,4228,121,2.73 [2.10-3.54],6.151981463561187e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,4080,118,4.22 [3.05-5.85],5.046320466670017e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,4080,118,5.70 [4.21-7.73],3.0747162435132825e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,4228,121,1.96 [1.55-2.48],2.3041749507742692e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,4080,118,1.99 [1.73-2.29],2.3163998555649512e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,4197,122,9.01 [6.50-12.49],1.121800101200962e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,4228,121,3.16 [2.12-4.71],1.7392843803998352e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,4088,118,1.62 [1.41-1.86],8.13765096248864e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,4191,121,13.03 [8.18-20.74],2.7780268768208047e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,4158,121,3.96 [3.12-5.03],7.872674379568612e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,4174,120,4.57 [3.46-6.06],2.3634980966334806e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,4181,121,10.40 [4.69-23.08],8.344334001190774e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,3607,90,2.16 [1.63-2.85],6.960377891068834e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,3556,85,3.45 [2.58-4.61],4.616861095464382e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,3607,90,2.15 [1.74-2.65],1.8477832297502215e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,4080,118,7.07 [4.33-11.55],5.654789376652958e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,3629,87,2.36 [1.77-3.16],6.572399272329507e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,4197,122,4.27 [2.80-6.49],1.2199966101351292e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,4212,121,13.26 [9.80-17.94],4.3483474731817865e-63
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,4161,121,3.76 [2.65-5.33],9.022245640681436e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,3602,87,3.89 [2.72-5.56],8.682900678155375e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,4054,117,2.66 [1.99-3.55],3.4374140092645746e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,4181,121,3.52 [2.37-5.22],3.63617990224952e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,4172,121,2.41 [1.79-3.26],7.58409491616598e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,4140,121,5.67 [4.52-7.11],1.1952298102394973e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,4215,123,2.51 [1.84-3.42],7.290341882040796e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,4215,123,2.44 [2.10-2.85],3.757741815171952e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,4179,121,6.29 [4.31-9.19],1.6728631940245824e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,4026,118,4.46 [3.32-5.99],3.352160398193699e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,4228,121,7.57 [5.78-9.92],1.0344997426443804e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,4228,121,3.14 [2.32-4.26],1.712118408549829e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,3602,87,3.32 [2.39-4.61],7.956465708162276e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",4165,119,2.39 [2.02-2.83],3.0729280005855862e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,4161,121,2.41 [1.99-2.92],2.686114799970824e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,4176,120,3.54 [2.95-4.26],1.4571256669559106e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,4198,120,3.64 [2.45-5.40],1.3526926897685618e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,4137,120,7.53 [6.02-9.42],1.0468160777001592e-69
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,3616,90,1.71 [1.44-2.02],4.802157938027634e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,4057,117,3.72 [2.98-4.64],2.9839797678243846e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,4181,121,4.46 [3.14-6.32],5.0911313148117275e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,4184,122,5.00 [3.15-7.95],1.0398580994308068e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,4176,120,3.34 [2.73-4.09],1.0081984283285358e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,4174,122,2.85 [2.28-3.56],3.180246328783111e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,4182,120,8.97 [5.96-13.51],7.257107250718891e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,4174,120,7.06 [4.73-10.53],1.060981757923898e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,4181,121,5.81 [3.61-9.34],4.333702944831889e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,4080,118,4.26 [3.19-5.68],7.866176716139092e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,3602,87,5.12 [3.63-7.23],1.2817876037974635e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,3616,90,4.34 [3.28-5.74],8.374438297219788e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,3631,89,6.38 [3.26-12.50],6.45875477986361e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,4203,123,3.05 [2.13-4.38],1.2820508933934522e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,4181,121,8.16 [6.01-11.09],4.3091517313128254e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,4232,123,5.94 [4.37-8.09],1.0409258023389652e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,4158,120,8.37 [6.41-10.93],6.297390131392932e-55
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,4155,120,3.87 [3.11-4.83],2.077228716031739e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,4126,120,1.61 [1.35-1.91],8.01932627952277e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,3615,89,4.98 [3.49-7.11],9.640920305545269e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,4185,121,11.27 [7.41-17.14],9.86473753009122e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,4185,120,5.15 [3.14-8.43],7.88569002863311e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,4232,123,2.03 [1.66-2.49],9.58433339897642e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,4197,122,2.67 [1.87-3.81],6.477620981709057e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,4173,121,2.21 [1.82-2.68],8.732120863800028e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,3615,89,4.89 [2.97-8.06],4.4780425207848734e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,4228,121,4.55 [2.76-7.48],2.5639074181529046e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,3556,85,4.48 [2.59-7.74],7.973989416286594e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,4232,123,5.76 [4.16-7.96],4.179183256477747e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,4185,121,3.33 [2.33-4.77],3.909373053994348e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,4172,120,2.62 [2.12-3.24],6.824106286869191e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,4185,123,2.31 [1.85-2.88],1.9644720108529058e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,4195,121,2.30 [1.82-2.92],5.036940429413366e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,4102,122,6.08 [4.56-8.10],9.181192165028178e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,4215,123,5.51 [3.95-7.69],9.59804647652899e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,3632,90,6.62 [3.64-12.05],5.939654506504703e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,4149,120,1.89 [1.50-2.38],7.51326588413231e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,4180,120,2.40 [2.00-2.87],1.9250860331662906e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,4212,121,2.66 [1.94-3.65],1.0736976638254471e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,4054,117,2.18 [1.77-2.68],3.053326440194543e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,4191,120,2.16 [1.64-2.84],5.272499835263253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,4185,121,20.96 [14.38-30.56],1.9135396480608814e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,4171,120,6.71 [5.12-8.78],1.4852186488689429e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,3602,89,9.25 [6.12-13.97],3.96944054968924e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,4215,123,10.27 [6.52-16.18],1.0523993563316105e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,4181,121,10.34 [7.76-13.77],2.0610369816624491e-57
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,4185,121,4.52 [3.77-5.43],2.369613551683898e-59
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,4040,115,3.32 [2.83-3.90],1.4682040089076314e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,4185,121,0.38 [0.29-0.50],5.859163403213601e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,3616,90,3.26 [2.17-4.91],1.494223134849868e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,4228,121,6.21 [4.02-9.60],2.0905900261946795e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",4054,117,2.30 [1.88-2.82],6.98261015847984e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,4232,123,28.81 [12.09-68.67],3.3733770751303794e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,3629,87,8.41 [4.55-15.55],1.0888601858780491e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,4232,123,3.68 [2.53-5.37],1.2651657462077094e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,3578,86,13.45 [8.91-20.30],3.5829895523616697e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,4181,121,5.77 [4.58-7.27],3.969883971138149e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,4107,122,1.41 [1.27-1.56],5.760627207839215e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,4174,120,2.06 [1.68-2.52],3.712230073260013e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,4215,123,2.45 [1.89-3.18],1.9171775417889985e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,4200,122,5.36 [3.26-8.81],3.624349185318212e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,3602,87,3.06 [2.33-4.02],1.0558935098434368e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,4181,121,1.59 [1.45-1.76],4.3905831934539015e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,4210,123,4.73 [3.33-6.71],4.243964424265821e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,3506,87,10.69 [5.96-19.15],1.7658758637260077e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,3616,90,4.58 [3.37-6.24],3.2799923702645253e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,4161,121,3.24 [2.10-4.99],9.889082887690632e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,4195,121,5.98 [4.73-7.56],1.6736020378620804e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,4185,120,6.39 [4.15-9.84],3.5034283796270376e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,3584,88,7.67 [5.42-10.84],9.383210555615454e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,3602,87,5.22 [3.82-7.14],4.136660391139722e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,4215,123,9.17 [5.78-14.55],4.480194628686944e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,3602,89,4.34 [2.79-6.73],5.980150978849475e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,4208,121,3.81 [2.38-6.09],2.498920621338512e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,3602,89,2.70 [2.03-3.60],1.1831726041266305e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,4211,123,2.63 [2.08-3.32],9.332536810206589e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,4161,121,5.97 [4.47-7.98],1.485540905683574e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,4181,121,5.86 [3.91-8.78],1.182126116929704e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,4232,123,7.78 [4.07-14.88],5.684849463471225e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,3556,85,6.36 [4.51-8.97],4.653923945041443e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,4228,121,10.39 [7.62-14.16],1.1711091992034714e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,4215,123,2.80 [2.18-3.60],7.057032354855917e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,3602,89,3.80 [2.82-5.12],1.4197648623065522e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,4145,120,7.08 [4.62-10.83],2.0976357135699432e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,3632,90,18.64 [8.60-40.41],1.2857122558422314e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,4130,122,2.26 [1.94-2.63],8.908972796982272e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,4139,119,3.23 [2.40-4.35],1.1844330015458202e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,4195,121,12.16 [9.29-15.93],9.112125820215393e-74
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,4195,121,6.26 [4.34-9.02],8.119483074830155e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,4181,121,3.77 [2.73-5.20],8.017023997449919e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,3615,89,8.97 [4.56-17.63],2.0110147135909077e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,4145,120,2.15 [1.65-2.80],1.2723378348806056e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,4195,121,0.35 [0.24-0.51],5.042899495555922e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,4157,120,10.84 [7.53-15.61],1.4684421761564126e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,4181,121,2.34 [1.72-3.19],6.590044166888724e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,4212,122,6.28 [4.16-9.50],3.092871084007359e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,4185,121,4.66 [2.98-7.30],1.5861524012879275e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,3506,87,2.24 [1.71-2.93],3.5314311124796222e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",4161,121,2.26 [1.79-2.84],4.425181889866271e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,3506,87,2.82 [1.96-4.05],2.0169169370231505e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,3616,90,2.60 [2.06-3.29],7.17132975149838e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,3629,87,5.52 [3.19-9.57],1.0965470699313507e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,4080,118,2.70 [1.97-3.72],9.660392354081184e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,4176,120,8.15 [5.18-12.81],9.834770681547084e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,3629,87,3.43 [2.53-4.64],1.609516212872037e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,3520,84,4.12 [3.07-5.52],2.482219498215893e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,3506,87,2.55 [1.90-3.42],4.5902388194342766e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,4172,121,4.08 [2.85-5.86],2.192771042844448e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,4167,120,4.62 [3.31-6.47],3.788323061106175e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,3604,87,13.13 [7.43-23.20],7.6917729323597935e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,3602,89,2.49 [1.84-3.38],4.381357100705366e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,4155,122,6.32 [4.97-8.03],1.5595858250364234e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,4174,120,1.86 [1.52-2.29],2.4707353050609663e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,4054,117,3.70 [2.65-5.17],1.4746192211539664e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,4132,120,4.70 [3.72-5.93],2.358189425064748e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,3602,87,3.72 [2.54-5.43],1.183505893393541e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,4232,123,8.18 [5.54-12.09],4.453955138553743e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,3499,84,1.57 [1.34-1.84],4.0012050429340094e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,4191,123,17.15 [10.81-27.23],1.793811879312415e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,4058,119,2.58 [1.95-3.42],3.929689206367397e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,4200,122,2.27 [1.81-2.85],1.9950517915688807e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,4161,121,2.13 [1.84-2.48],3.570860464586075e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,4161,121,1.93 [1.54-2.42],9.570705619579745e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,4161,121,3.69 [3.09-4.41],8.695623289926344e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,4232,123,2.83 [2.38-3.37],2.2818625286114776e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,4232,123,2.83 [2.38-3.35],8.218070185500392e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,4185,120,3.78 [2.99-4.78],9.093356733661352e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,4195,121,10.05 [7.39-13.66],3.845391237888397e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,4181,121,1.85 [1.62-2.11],1.159601066541375e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,4179,121,3.13 [2.47-3.97],4.4443275401423085e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,4212,121,6.75 [4.31-10.58],8.309816188706598e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,4212,121,10.97 [7.59-15.83],2.228092825355441e-37
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,3632,90,11.09 [7.27-16.93],6.79151690953656e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,3520,84,2.37 [1.84-3.05],2.3995257387038943e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,3501,87,6.26 [4.20-9.35],2.5120396482089645e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,3602,89,2.60 [2.10-3.21],1.195926590410049e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,4218,123,5.51 [4.38-6.94],1.2022110455262301e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,3520,84,9.14 [6.28-13.31],8.034064935782802e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,4181,121,9.97 [6.94-14.33],1.4706312561293285e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,4145,120,4.09 [2.71-6.19],2.3491201742705484e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,4215,123,7.31 [5.45-9.81],4.9275708649449716e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,4161,121,3.08 [2.52-3.77],1.1775185228030316e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,4215,123,5.17 [3.65-7.32],1.864850548232385e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,3621,87,3.70 [2.33-5.89],3.35367858961089e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,4212,121,11.05 [7.97-15.31],3.484429916392282e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,4060,120,7.35 [5.85-9.22],2.1896135515736225e-66
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,4232,123,2.76 [1.98-3.86],2.7091643002968283e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,4212,121,7.53 [5.61-10.11],3.5634615965825207e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,4198,123,12.28 [8.63-17.47],4.2651036597713307e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,4185,120,3.74 [2.39-5.87],8.550744645573208e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,4185,120,3.83 [2.82-5.19],5.400966902238386e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,4080,118,3.24 [2.50-4.19],4.0768797907876456e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,3520,84,3.66 [2.75-4.88],9.372998308798145e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,3615,89,7.28 [4.49-11.80],8.237444086769251e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,4181,121,3.11 [2.41-4.00],1.3067411932987797e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,3520,84,2.68 [2.01-3.57],2.1189470674014872e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,4181,121,9.28 [5.65-15.24],1.3656045115998637e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,4222,123,3.11 [2.09-4.64],2.41087588298727e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,3594,87,3.61 [2.66-4.89],1.4158267483412911e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,3570,89,7.95 [3.99-15.84],3.711174599414322e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,4185,121,6.88 [4.82-9.82],1.9928588849424908e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,4133,120,2.50 [2.01-3.10],9.577952955306008e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,3629,87,7.10 [5.12-9.84],6.483345119386259e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,4198,120,3.58 [2.67-4.80],1.371071962997441e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,4174,120,4.17 [3.19-5.44],1.069411246081424e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,4195,121,1.72 [1.42-2.08],3.7688533386625364e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,4215,123,6.35 [4.33-9.31],3.1382479326795975e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,4168,120,5.40 [4.13-7.08],1.6222091097255687e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,4080,118,2.08 [1.65-2.62],5.372408427676285e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,4174,120,1.98 [1.55-2.52],3.2618332829659125e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,4054,117,2.17 [1.81-2.60],9.538898599341182e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,4174,120,1.77 [1.53-2.05],1.7087115195977745e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,4215,123,3.47 [2.38-5.06],9.052958585655331e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,4107,122,5.50 [4.01-7.55],5.514818148891235e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,3598,87,3.16 [2.34-4.28],9.10369288142354e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,4215,123,4.18 [2.92-5.99],5.633786691695176e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,4198,120,4.98 [3.88-6.40],3.323322636365217e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,4145,120,3.44 [2.78-4.25],2.4322475982393453e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,4058,119,7.09 [5.30-9.48],6.822508887760185e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,4173,121,4.72 [2.94-7.58],1.2569455617244568e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,4195,121,4.13 [3.37-5.06],1.2338690182547958e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,3556,85,4.30 [2.87-6.44],1.4483433437456365e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,4174,120,3.02 [2.53-3.59],2.5848325230694256e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,4195,121,6.18 [4.26-8.98],9.298142715583441e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,4215,123,2.62 [1.94-3.54],3.3952135940805176e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,4184,121,3.75 [2.45-5.73],1.1925379307857395e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,4198,120,4.03 [2.95-5.49],1.2721399575875622e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,4185,120,4.94 [3.67-6.64],4.372436333313154e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,4167,121,10.26 [7.19-14.62],6.850961038465283e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,4225,123,3.53 [2.75-4.54],1.0014616619957849e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,3602,87,1.95 [1.58-2.41],4.737994656462678e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4161,121,1.95 [1.55-2.46],1.1702604088175113e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",4232,123,4.19 [2.57-6.80],7.687906760298696e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,4212,121,2.33 [1.76-3.08],3.3690347036410805e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,3540,84,8.89 [5.34-14.81],4.5833692555493836e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,3602,87,2.15 [1.63-2.85],7.946095174646756e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,3704,112,5.92 [3.80-9.23],4.078967979722413e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,4161,121,5.91 [4.64-7.52],3.007919735055416e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,4225,123,4.28 [3.24-5.66],1.6211761790814103e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,4175,121,2.18 [1.92-2.47],2.174145177454092e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,4192,120,2.81 [2.36-3.35],9.683039102460856e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,4158,120,2.81 [2.42-3.27],1.2114092463523236e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,4177,121,1.81 [1.48-2.22],1.0945927537806742e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,4174,120,2.67 [2.07-3.45],6.054387947096935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,4185,121,5.40 [4.44-6.56],1.0377032486594012e-64
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,4232,123,6.74 [4.82-9.43],8.06867903015006e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,3632,90,13.42 [8.92-20.21],1.49034772373866e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,4181,121,6.96 [5.20-9.31],4.8594596802173095e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,4212,121,8.91 [6.18-12.84],9.156186797269248e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,4128,120,5.80 [4.29-7.84],3.2899211855644575e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,4195,121,2.58 [1.88-3.56],5.747619790749765e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,4175,121,15.51 [8.41-28.61],1.7292599219250597e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,3594,87,3.13 [2.36-4.15],2.258152186074024e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,4104,122,2.20 [1.85-2.61],3.1942333184737245e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,4145,120,3.90 [3.22-4.73],1.5968906505718229e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,4145,120,1.74 [1.57-1.93],4.156268299253097e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,4228,121,5.91 [4.74-7.36],1.6864922705199696e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,4176,120,3.53 [2.35-5.30],1.1886663371588979e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,4185,121,7.72 [5.87-10.17],4.4575939748160113e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,4185,120,3.52 [2.86-4.33],2.136693484771796e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,4185,120,7.41 [5.76-9.54],1.4086778030991982e-54
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,3556,85,4.59 [2.91-7.26],6.622330368261809e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,4215,123,5.63 [4.54-6.98],4.9051165949013265e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,4195,121,13.50 [10.08-18.08],3.1344984633169168e-68
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,4195,121,2.09 [1.84-2.36],3.2118372890753993e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,4212,121,14.38 [9.65-21.43],3.287392322072269e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,4220,121,6.12 [4.73-7.91],2.9221666387742243e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,4145,120,2.40 [1.98-2.91],5.050905866279736e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,4212,121,2.69 [2.12-3.42],4.843795532824098e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,4145,120,3.36 [2.84-3.97],2.4992161262670848e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,4198,120,9.32 [5.91-14.68],6.5478448261103865e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,4195,121,3.58 [2.45-5.23],4.3612309332872866e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,4145,120,7.73 [5.70-10.48],1.3516983602488864e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,4218,121,0.34 [0.28-0.43],3.773872072619667e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,3602,87,2.25 [1.70-2.98],1.2652086195392825e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,4121,120,6.69 [4.42-10.12],2.2882675126950843e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,4196,122,5.58 [3.66-8.51],1.4951908877897685e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,4215,121,2.01 [1.57-2.56],2.047875584854298e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,4221,121,4.36 [3.11-6.12],1.2824136870549914e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,3616,90,3.24 [2.28-4.63],7.995343474867449e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,4161,121,2.42 [1.86-3.14],3.049500781781283e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,3607,90,2.38 [1.94-2.94],3.329742498796911e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,4188,120,6.89 [5.41-8.77],1.836298443908909e-55
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,4130,120,7.78 [5.73-10.57],2.1778736528550213e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,4209,123,2.03 [1.65-2.51],4.330058788952848e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,3974,111,5.43 [4.47-6.60],6.17649121577685e-65
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",4185,120,4.04 [2.61-6.25],3.487553918340829e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,4080,118,3.69 [2.92-4.68],2.177799597321937e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,4215,123,1.71 [1.43-2.04],4.346257090513604e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,4208,123,6.60 [5.07-8.59],9.102511310511673e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,3602,87,12.59 [8.44-18.76],1.6392592086720302e-35
